These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1611299)

  • 1. Stimulation of matrix vesicle enzyme activity in osteoblast-like cells by 1,25(OH)2D3 and transforming growth factor beta (TGF beta).
    Bonewald LF; Schwartz Z; Swain LD; Boyan BD
    Bone Miner; 1992 May; 17(2):139-44. PubMed ID: 1611299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of prostaglandin E2 synthesis and phospholipase A2 activity by 1,25-(OH)2D3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63).
    Schwartz Z; Dennis R; Bonewald L; Swain L; Gomez R; Boyan BD
    Bone; 1992; 13(1):51-8. PubMed ID: 1581109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor-beta in osteosarcoma cell cultures.
    Bonewald LF; Schwartz Z; Swain LD; Ramirez V; Poser J; Boyan BD
    J Cell Physiol; 1990 Nov; 145(2):200-6. PubMed ID: 2246323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 1,25-(OH)2D3- and 24,25-(OH)2D3-dependent stimulation of alkaline phosphatase activity by A23187 suggests a role for calcium in the mechanism of vitamin D regulation of chondrocyte cultures.
    Schwartz Z; Langston GG; Swain LD; Boyan BD
    J Bone Miner Res; 1991 Jul; 6(7):709-18. PubMed ID: 1659121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner.
    Dean DD; Boyan BD; Muniz OE; Howell DS; Schwartz Z
    Calcif Tissue Int; 1996 Aug; 59(2):109-16. PubMed ID: 8687979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface roughness mediates its effects on osteoblasts via protein kinase A and phospholipase A2.
    Boyan BD; Sylvia VL; Liu Y; Sagun R; Cochran DL; Lohmann CH; Dean DD; Schwartz Z
    Biomaterials; 1999 Dec; 20(23-24):2305-10. PubMed ID: 10614936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities.
    Schwartz Z; Schlader DL; Swain LD; Boyan BD
    Endocrinology; 1988 Dec; 123(6):2878-84. PubMed ID: 3264240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins mediate the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner.
    Schwartz Z; Gilley RM; Sylvia VL; Dean DD; Boyan BD
    Bone; 1999 May; 24(5):475-84. PubMed ID: 10321907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells.
    Ingram RT; Bonde SK; Riggs BL; Fitzpatrick LA
    Differentiation; 1994 Jan; 55(2):153-63. PubMed ID: 8143932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of 1,25-(OH)2D3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture.
    Boyan BD; Schwartz Z; Bonewald LF; Swain LD
    J Biol Chem; 1989 Jul; 264(20):11879-86. PubMed ID: 2545688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
    Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
    J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro.
    Schwartz Z; Boyan B
    Endocrinology; 1988 May; 122(5):2191-8. PubMed ID: 3258818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3.
    Boyan BD; Schwartz Z; Park-Snyder S; Dean DD; Yang F; Twardzik D; Bonewald LF
    J Biol Chem; 1994 Nov; 269(45):28374-81. PubMed ID: 7961777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner.
    Schwartz Z; Bonewald LF; Caulfield K; Brooks B; Boyan BD
    Endocrinology; 1993 Apr; 132(4):1544-52. PubMed ID: 8462452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix vesicles as a marker of endochondral ossification.
    Boyan BD; Schwartz Z; Swain LD
    Connect Tissue Res; 1990; 24(1):67-75. PubMed ID: 2338026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG; Klein-Nulend J; Burger EH; Lips P
    J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma hybrids can preferentially target alkaline phosphatase activity to matrix vesicles: evidence for independent membrane biogenesis.
    Leach RJ; Schwartz Z; Johnson-Pais TL; Dean DD; Luna M; Boyan BD
    J Bone Miner Res; 1995 Nov; 10(11):1614-24. PubMed ID: 8592937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of resting zone chondrocytes with transforming growth factor-beta 1 induces differentiation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25-(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.
    Schwartz Z; Sylvia VL; Liu Y; Dean DD; Boyan BD
    Bone; 1998 Nov; 23(5):465-70. PubMed ID: 9823454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 pretreatment limits prostaglandin biosynthesis by cytokine-stimulated adult human osteoblast-like cells.
    Keeting PE; Li CH; Whipkey DL; Thweatt R; Xu J; Murty M; Blaha JD; Graeber GM
    J Cell Biochem; 1998 Feb; 68(2):237-46. PubMed ID: 9443079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24,25-(OH)2D3 regulation of matrix vesicle protein kinase C occurs both during biosynthesis and in the extracellular matrix.
    Sylvia VL; Schwartz Z; Holmes SC; Dean DD; Boyan BD
    Calcif Tissue Int; 1997 Oct; 61(4):313-21. PubMed ID: 9312202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.